Trial Profile
PHASE II CLINICAL EVALUATION OF PYRAZOLOACRIDINE IN PATIENTS WITH METASTATIC BREAST CANCER.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2011
Price :
$35
*
At a glance
- Drugs PD 115934 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Oct 2005 New trial record.